891161

Shire Human Genetic Therapies, Inc. — FEI 3009340644

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 6, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report